HCPCS codes

22720 HCPCS codes with hospital pricing data in the network.

• HCPCS Q9967 — Iodixanol contrast injection, 320 mg/mLAI (2408 hospitals, 801,739,528–802,140,001 samples)
• HCPCS J2704 — Propofol intravenous emulsionAI (2348 hospitals, 186,296,303–186,487,589 samples)
• HCPCS J2003 — Lidocaine local anesthetic injection, preservative-free 1%AI (2006 hospitals, 160,429,681–160,769,152 samples)
• HCPCS J0131 — Acetaminophen 1000 mg injectionAI (1994 hospitals, 156,375,275–156,388,199 samples)
• HCPCS C1713 — Cannulated stainless steel femoral locking bone screwAI (2125 hospitals, 14,994,063–148,470,291 samples)
• HCPCS A9575 — Gadoterate meglumine contrast, 15 mLAI (1578 hospitals, 117,728,243–117,742,841 samples)
• HCPCS J7120 — Lactated Ringer's solution infusionAI (2286 hospitals, 112,798,491–112,885,512 samples)
• HCPCS J9190 — Fluorouracil injection, 500 mgAI (2100 hospitals, 75,183,495–75,193,593 samples)
• HCPCS J9299 — Injection of nivolumab, per milligramAI (1973 hospitals, 74,580,435–74,587,104 samples)
• HCPCS J2371 — Phenylephrine hydrochloride injection 10 mg/mLAI (2224 hospitals, 58,061,251–58,125,565 samples)
• HCPCS J2350 — Injection of ocrelizumab, per 1 mgAI (1887 hospitals, 50,463,187–50,465,734 samples)
• HCPCS J7030 — Normal saline IV solution 0.9%AI (2236 hospitals, 50,096,224–50,189,707 samples)
• HCPCS Q0138 — Ferumoxytol injection for iron deficiency anemiaAI (2081 hospitals, 35,543,016–35,547,660 samples)
• HCPCS C1776 — Posterior-stabilized knee implant insertAI (2007 hospitals, 3,415,594–33,793,996 samples)
• HCPCS J0665 — Bupivacaine local anesthetic injection, preservative-freeAI (2226 hospitals, 23,530,605–23,844,435 samples)
• HCPCS J2004 — Lidocaine with epinephrine injectionAI (1873 hospitals, 14,623,594–14,797,258 samples)
• HCPCS J1836 — Metronidazole IV solution, 500 mg per 100 mLAI (2172 hospitals, 10,885,799–10,900,181 samples)
• HCPCS J7050 — Sodium chloride (saline) IV solutionAI (2125 hospitals, 10,317,553–10,533,706 samples)
• HCPCS J2795 — Ropivacaine hydrochloride injectionAI (2277 hospitals, 10,154,985–10,237,776 samples)
• HCPCS C1889 — Vascular embolization coil, bare platinum 3DAI (1978 hospitals, 977,983–9,054,493 samples)
• HCPCS J0666 — Bupivacaine liposome injection, per milligramAI (1776 hospitals, 8,974,323–8,982,990 samples)
• HCPCS J7040 — Sodium chloride 0.9% IV solutionAI (2101 hospitals, 8,174,324–8,254,820 samples)
• HCPCS J9022 — Injection of atezolizumab, per 10 mgAI (1910 hospitals, 7,507,390–7,509,325 samples)
• HCPCS J0169 — Adrenaline (epinephrine) injectionAI (1425 hospitals, 6,960,561–6,969,453 samples)
• HCPCS J3480 — Potassium chloride injection, 2 mEq per mLAI (2391 hospitals, 6,082,755–6,197,370 samples)
• HCPCS Q9958 — Iodinated contrast dye, per milliliterAI (1820 hospitals, 5,588,824–5,598,355 samples)
• HCPCS C1769 — Discontinued guide wire kitAI (2198 hospitals, 601,853–5,224,964 samples)
• HCPCS J3490 — Flumazenil IV injectionAI (2137 hospitals, 1,954,561–5,123,191 samples)
• HCPCS J2404 — Nicardipine IV solution, 2.5 mg/mLAI (2074 hospitals, 5,022,764–5,029,613 samples)
• HCPCS J1756 — Iron sucrose injection, 20 mg per mLAI (2308 hospitals, 4,613,337–4,629,942 samples)
• HCPCS C1874 — Biliary stent, 8.5 French, 8 by 60 mmAI (1960 hospitals, 455,137–4,474,150 samples)
• HCPCS J7042 — Dextrose 5% and sodium chloride 0.9% IV solutionAI (2168 hospitals, 4,373,500–4,389,520 samples)
• HCPCS C1725 — Balloon angioplasty catheter, over-the-wire, 3.5mmAI (1979 hospitals, 437,288–4,175,627 samples)
• HCPCS J8499 — Hydroxychloroquine 200 mg oral tabletAI (1146 hospitals, 682,929–4,161,906 samples)
• HCPCS G0463 — Unscheduled hospital outpatient clinic visitAI (1779 hospitals, 3,694,460–3,822,593 samples)
• HCPCS C1887 — CPS Aim SL inner catheterAI (2002 hospitals, 401,032–3,740,743 samples)
• HCPCS J9358 — Fam-trastuzumab deruxtecan injection, per 1 mgAI (1721 hospitals, 3,645,121–3,646,507 samples)
• HCPCS C1894 — Introducer catheter, 7 French, 100 cmAI (2083 hospitals, 348,484–2,941,456 samples)
• HCPCS J9173 — Injection of durvalumab, per 10 mgAI (1830 hospitals, 2,765,996–2,769,443 samples)
• HCPCS J9271 — Pembrolizumab injection, per 1 mgAI (1990 hospitals, 2,730,143–2,736,038 samples)
• HCPCS G0378 — Observation care, per hourAI (2389 hospitals, 2,508,546–2,622,891 samples)
• HCPCS J2315 — Naltrexone depot injection, per 1 mgAI (1527 hospitals, 2,615,232–2,615,718 samples)
• HCPCS C1781 — Phasix mesh plug and patchAI (2086 hospitals, 273,946–2,590,420 samples)
• HCPCS Q5101 — Injection of filgrastim-sndz (Zarxio), per microgramAI (1942 hospitals, 2,256,391–2,261,773 samples)
• HCPCS J1642 — Heparin lock flush injection, per 10 unitsAI (2280 hospitals, 2,057,890–2,132,527 samples)
• HCPCS J9264 — Paclitaxel protein-bound injection, per 1 mgAI (1987 hospitals, 1,965,389–1,968,791 samples)
• HCPCS V2632 — Intraocular lens implant, posterior chamberAI (1827 hospitals, 202,118–1,922,594 samples)
• HCPCS P9045 — Albumin 5% intravenous solution, 500 mLAI (2030 hospitals, 1,892,332–1,905,481 samples)
• HCPCS C2617 — Ureteral stent, 6 French, 24 cmAI (1968 hospitals, 201,658–1,785,100 samples)
• HCPCS J7070 — Dextrose 5% in water infusionAI (2001 hospitals, 1,736,725–1,741,279 samples)